Novel gene target reveals antidepressant mechanism of electroconvulsive therapy

A study from John Hopkins Medicine (MD, USA) has demonstrated that electroconvulsive therapy (ECT) may aid depression symptoms by acting upon a novel target, the immediate early gene Narp within the hippocampus.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please Login or Register to view this area.

depression ECT genetics mouse model